{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:12:57Z","timestamp":1792678377323,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:00:00Z","timestamp":1307923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020733","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:18:34Z","timestamp":1308341914000},"page":"e20733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations"],"prefix":"10.1371","volume":"6","author":[{"given":"Manuela","family":"Vecsler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruria","family":"Ben Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Anikster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninette","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Rechavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timor","family":"Baasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,13]]},"reference":[{"key":"ref1","first-page":"5","article-title":"Rett syndrome: epidemiology and geographical variability.","volume":"6","author":"B Hagberg","year":"1997","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.","volume":"23","author":"RE Amir","year":"1999","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/humu.10194","article-title":"RettBASE: The IRSA MECP2 variation database-a new mutation database in evolution.","volume":"21","author":"J Christodoulou","year":"2003","journal-title":"Hum Mutat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/S0387-7604(01)00339-4","article-title":"Spectrum of MECP2 mutations in Rett syndrome.","volume":"23","author":"SS Lee","year":"2001","journal-title":"Brain Dev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/320109","article-title":"MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.","volume":"68","author":"R Trappe","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO;2-F","article-title":"Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.","volume":"47","author":"RE Amir","year":"2000","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2004.023804","article-title":"Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome.","volume":"42","author":"M Meins","year":"2005","journal-title":"J Med Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.","volume":"77","author":"H Van Esch","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/nar\/gkh349","article-title":"The major form of MeCP2 has a novel N-terminus generated by alternative splicing.","volume":"32","author":"S Kriaucionis","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng1327","article-title":"A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome.","volume":"36","author":"GN Mnatzakanian","year":"2004","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/MCB.16.1.414","article-title":"DNA methylation specifies chromosomal localization of MeCP2.","volume":"16","author":"X Nan","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.","volume":"19","author":"PL Jones","year":"1998","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.","volume":"393","author":"X Nan","year":"1998","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.","volume":"302","author":"WG Chen","year":"2003","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.","volume":"302","author":"K Martinowich","year":"2003","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription.","volume":"320","author":"M Chahrour","year":"2008","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.","volume":"102","author":"JI Young","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.","volume":"37","author":"PJ Skene","year":"2010","journal-title":"Mol Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.","volume":"27","author":"RZ Chen","year":"2001","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.","volume":"27","author":"J Guy","year":"2001","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.","volume":"104","author":"E Giacometti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome.","volume":"315","author":"J Guy","year":"2007","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.","volume":"13","author":"AL Collins","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.3","article-title":"Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions.","volume":"17","author":"F Laccone","year":"2001","journal-title":"Hum Mutat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin.","volume":"13","author":"JF Burke","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1172\/JCI8055","article-title":"Correction of genetic disease by making sense from nonsense.","volume":"104","author":"RJ Kaufman","year":"1999","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.","volume":"6","author":"M Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.","volume":"104","author":"ER Barton-Davis","year":"1999","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a Cftr\u2212\/\u2212 mouse carrying a human CFTR-G542X transgene.","volume":"80","author":"M Du","year":"2002","journal-title":"J Mol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.mcp.0000141247.22078.46","article-title":"Pharmacologic therapy for stop mutations: how much CFTR activity is enough?","volume":"10","author":"E Kerem","year":"2004","journal-title":"Curr Opin Pulm Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","article-title":"Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics.","volume":"65","author":"C Brendel","year":"2009","journal-title":"Pediatr Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157016005774913149","article-title":"Pharmacological Suppression of Premature Stop Mutations that Cause Genetic Diseases.","volume":"3","author":"KM Keeling","year":"2005","journal-title":"Current Pharmacogenomics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B712690P","article-title":"Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.","volume":"6","author":"M Hainrichson","year":"2008","journal-title":"Org Biomol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1167\/iovs.10-5741","article-title":"Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina.","volume":"51","author":"T Goldmann","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.","volume":"52","author":"I Nudelman","year":"2009","journal-title":"J Med Chem"},{"key":"ref36","first-page":"15","article-title":"Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results.","volume":"22","author":"L Politano","year":"2003","journal-title":"Acta Myol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.","volume":"49","author":"KR Wagner","year":"2001","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2001-0004OC","article-title":"Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.","volume":"27","author":"AS Ramalho","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro.","volume":"88","author":"AC Popescu","year":"2010","journal-title":"J Neurosci Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.","volume":"48","author":"MT Howard","year":"2000","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.","volume":"89","author":"C Brendel","year":"2011","journal-title":"J Mol Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/epi.5.1.10630","article-title":"MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro.","volume":"5","author":"M Vecsler","year":"2010","journal-title":"Epigenetics"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.gt.3302211","article-title":"Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment.","volume":"11","author":"L Bidou","year":"2004","journal-title":"Gene Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.","volume":"67","author":"V Malik","year":"2010","journal-title":"Ann Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0168-9525(98)01658-8","article-title":"RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer.","volume":"15","author":"MR Culbertson","year":"1999","journal-title":"Trends Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00018-007-7034-x","article-title":"Aminoglycoside antibiotics: old drugs and new therapeutic approaches.","volume":"64","author":"T Hermann","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref47","first-page":"e56","article-title":"Comprehensive diagnosis of Rett&apos;s syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients.","volume":"44","author":"Y Petel-Galil","year":"2007","journal-title":"J Med Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.","volume":"117","author":"L Linde","year":"2007","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2350-3-12","article-title":"Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations.","volume":"3","author":"J Traynor","year":"2002","journal-title":"BMC Med Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)81509-3","article-title":"BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.","volume":"98","author":"ZJ Huang","year":"1999","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function.","volume":"101","author":"LM Monteggia","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.","volume":"49","author":"Q Chang","year":"2006","journal-title":"Neuron"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1523\/JNEUROSCI.5503-09.2010","article-title":"Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice.","volume":"30","author":"DD Kline","year":"2010","journal-title":"J Neurosci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations.","volume":"447","author":"EM Welch","year":"2007","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T17:35:45Z","timestamp":1712511345000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020733"}},"subtitle":[],"editor":[{"given":"Mick F.","family":"Tuite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,13]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,13]]}}}